Market Access/ News/ News/ Top stories EU fines Teva and Cephalon €60.5m for ‘pay for delay’ scheme Richard Staines Cephalon, generic, litigation, modafinil, patent, Teva 0 Comment The European Union has fined Teva and its neurology unit Cephalon €60.5 million for an elaborate “pay for Share X EU fines Teva and Cephalon €60.5m for ‘pay for delay’ scheme https://pharmaphorum.com/news/eu-fines-teva-and-cephalon-e60-5m-for-pay-for-delay-scheme/
Cephalon, generic, litigation, modafinil, patent, Teva
0 Comment
